Arca
Skip to content
Tools
Tools

3',5'-cyclic phosphodiesterase

Family in Homo sapiens that 2 drugs act on.

  • Drugs that act on it: 2
  • Approved: 2
  • In phases 1 to 3: 0
  • Sponsors: 2
  • Genes: 23

Who is on it, and how far along

Every drug ChEMBL records acting on PDE10A, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 2

Approved2

  • Pentoxifylline
  • Dipyridamole

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        PentoxifyllineApprovedValidus PharmaceuticalsSmall moleculeInhibitor3',5'-cyclic phosphodiesterase inhibitor23
        DipyridamoleApprovedBoehringer Ingelheim PharmaceuticalsSmall moleculeInhibitor3',5'-cyclic phosphodiesterase inhibitor12

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 16 in all, from ClinicalTrials.gov.
        Non-Invasive Coronary Functional Evaluation of Patients With Single-vessel Coronary Artery DiseaseDipyridamoleNot applicableNot yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCSSep 4, 2026
        Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological EffectsDipyridamolePhase 1 / Phase 2Not yet recruitingHadassah Medical OrganizationJul 31, 2026
        Pentoxifylline Add-On Therapy for Mild-to-Moderate Plaque PsoriasisPentoxifyllineNot applicableNot yet recruitingWasuchon ChaichanJun 4, 2026
        Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer OutcomesPentoxifyllinePhase 3RecruitingBeni-Suef UniversityMar 30, 2026
        Non-invasive Evaluation of Patients With Angina and Non-obstructive Coronary Artery DiseaseDipyridamoleNot applicableNot yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCSFeb 20, 2026
        Pentoxifylline in Patients With Ulcerative ColitisPentoxifyllinePhase 2RecruitingIhab Elsayed HassanJan 16, 2026
        Effect of Pentoxifylline + CoQ10 vs CoQ10 Alone on Sperm Motility in Subfertile Men With AsthenozoospermiaPentoxifyllineNot applicableRecruitingMst.Sumyara KhatunNov 26, 2025
        A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With DipyridamoleDipyridamolePhase 2 / Phase 3RecruitingYunfeng XiaSep 30, 2025
        Nephroprotection Following Perinatal Asphyxia: Randomized Controlled TrialPentoxifyllineNot applicableNot yet recruitingAlexandria UniversityJul 28, 2025
        To Study Effect of Injection Pentoxifylline on Liver Growth After Major Liver SurgeryPentoxifyllineNot applicableRecruitingInstitute of Liver and Biliary Sciences, IndiaJul 25, 2025
        Cocaine and Pentoxifylline (BED IN 47)PentoxifyllineEarly phase 1RecruitingWilliam StoopsJul 25, 2025
        Comparison of the Efficacy of Mesotherapy and Extracorporeal Shock Wave Therapy in Patients With Lateral EpicondylitisPentoxifyllineNot applicableRecruitingHaydarpasa Numune Training and Research HospitalJun 29, 2025
        Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale StudyDipyridamole—Not yet recruitingNational University Hospital, SingaporeMay 21, 2025
        Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery StenosisDipyridamoleNot applicableRecruitingBeijing Tiantan HospitalMar 28, 2025
        Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant RecipientsDipyridamolePhase 2RecruitingStanford UniversityFeb 13, 2025
        Myocardial Perfusion Quantification With SPECT Using Multi-Pinhole Collimator Compared to Photon-Counting Coronary CTADipyridamoleNot applicableRecruitingSemmelweis UniversityNov 1, 2024

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2363066, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.